title: Rapid oral loading of carbamazepine in the emergency department.
abstract: OBJECTIVE
  This study evaluates the safety and efficacy of rapid oral loading of carbamazepine in the emergency department (ED).
  
  
  METHODS
  Adult patients receiving maintenance carbamazepine who presented with negligible levels received an oral load of carbamazepine suspension, with a dose of 8 mg/kg.
  
  
  RESULTS
  Forty-two oral loads among 36 patients were studied. Mean subject age was 36 years; 61% of the sample were male patients. The actual load administered ranged from 7.9 to 8.6 mg/kg. The mean 3-hour carbamazepine level (therapeutic 4 to 12 microg/mL) was 6.5 microg/mL (SD 2.0 microg/mL). Three patients had subtherapeutic levels after loading (successful loading rate 93%). Adverse effects occurred in 58% of patients, most commonly drowsiness (26%) and nausea (23%). Other adverse effects included dizziness, nystagmus, abdominal pain, vomiting, ataxia, and double vision. Two patients were treated for vomiting. All other adverse effects were mild and self-limited.
  
  
  CONCLUSIONS
  Rapid oral loading of carbamazepine in the ED in this cohort, although effective, was associated with a high rate of adverse effects. Given a sample size of 36, 95% confidence intervals suggest that the rate of serious adverse effects may be as high as 9.7% and that the rate of successful loading may be as low as 76.9%.
authors.affiliation: Department of Emergency Medicine, Kern Medical Center, Bakersfield, CA 93305, USA. purcellt@kernmedctr.com
authors.forename: Thomas B
authors.initials: TB
authors.lastname: Purcell
authors.forename: Rick A
authors.initials: RA
authors.lastname: McPheeters
authors.forename: Matthew
authors.initials: M
authors.lastname: Feil
authors.forename: Robert
authors.initials: R
authors.lastname: Chavez
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage* / Q000009:adverse effects; D002220:Carbamazepine / Q000008:administration & dosage* / Q000009:adverse effects; D015331:Cohort Studies; D004636:Emergency Service, Hospital; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine